Zhang, X., Zhang, S., Yang, X., Yang, J., Zhou, Q., Yin, L., . . . Wu, Y. (2010). Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. BioMed Central.
Stile di citazione ChicagoZhang, Xuchao, et al. Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression. BioMed Central, 2010.
Citazione MLAZhang, Xuchao, et al. Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression. BioMed Central, 2010.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.